DR. MERVYN MAZE, MB, CHB
Anesthesiologist Assistant at Parnassus Ave, San Francisco, CA
License number
California A30619
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
521 Parnassus Ave, San Francisco, CA 94143
Phone
(415) 476-9035
(415) 514-1532 (Fax)
(415) 514-1532 (Fax)
Organization information
See more information about MERVYN MAZE at bizstanding.comMervyn Maze MD
513 Parnassus Ave #S261, San Francisco, CA 94143
Categories:
Anesthesiology Physicians
Phone:
(415) 476-1411 (Phone)
Professional information
Dr. Mervyn Maze, San Francisco CA - MD (Doctor of Medicine)
Specialties:
Anesthesiology
Address:
UCSF Medical Center Anesthslgy
513 Parnassus Ave STE S261, San Francisco 94143
(415) 476-1411 (Phone)
513 Parnassus Ave STE S261, San Francisco 94143
(415) 476-1411 (Phone)
Certifications:
Anesthesiology, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Cape Town / Faculty of Health Sciences
University of Cape Town / Faculty of Health Sciences
Mervyn Maze, San Francisco CA
Specialties:
Anesthesiologist
Address:
521 Parnassus Ave, San Francisco, CA 94143
Use Of Hyperbaric Conditions To Provide Neuroprotection
US Patent:
2010031, Dec 16, 2010
Filed:
Apr 9, 2008
Appl. No.:
12/594890
Inventors:
Nicholas Peter Franks - Highbury, GB
Mervyn Maze - San Francisco CA, US
Juan Carlos Sacristan Martin - Madrid, ES
Mervyn Maze - San Francisco CA, US
Juan Carlos Sacristan Martin - Madrid, ES
Assignee:
AIR PRODUCTS AND CHEMICALS, INC. - Allentown PA
International Classification:
A61K 33/00, A61P 25/00
US Classification:
424600
Abstract:
Noble gases, in particular xenon and/or helium, administered under hyperbaric conditions of less than 3 atm (0.3 MPa), are used to provide neuroprotection, in particular in patients having suffered an impact trauma to the head and/or spinal column.
Methods
US Patent:
2013008, Apr 4, 2013
Filed:
Feb 17, 2011
Appl. No.:
13/579555
Inventors:
Mervyn Maze - San Francisco CA, US
Marc Feldman - London, GB
Niccolo Terrando - San Francisco CA, US
Mario Cibelli - London, GB
Daqing Ma - London, GB
Michael Fertleman - London, GB
Marc Feldman - London, GB
Niccolo Terrando - San Francisco CA, US
Mario Cibelli - London, GB
Daqing Ma - London, GB
Michael Fertleman - London, GB
Assignee:
IMPERIAL INNOVATIONS LIMITED - London
International Classification:
A61K 39/395
US Classification:
4241451
Abstract:
The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such planned inflammatory trigger can be a surgical procedure or chemotherapy. The invention further provides methods, uses and agents for reducing cognitive decline in a patient with a cognitive disorder, wherein said patient has been exposed to an inflammatory trigger. Pharmaceutical compositions and kits are also provided.